| Emily Grace Castillo, ARNP | |
|
55 W Tietan St, Walla Walla, WA 99362-4445 | |
| (509) 525-3720 | |
| (509) 522-1593 |
| Full Name | Emily Grace Castillo |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 55 W Tietan St, Walla Walla, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114261229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | AP60320121 (Washington) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | AP60320121 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grande Ronde Hospital | La grande, OR | Hospital |
| Providence St Mary Medical Center | Walla walla, WA | Hospital |
| St Anthony Hospital | Pendleton, OR | Hospital |
| Dayton General Hospital | Dayton, WA | Hospital |
| Wallowa Memorial Hospital | Enterprise, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Washington Pllc | 2264320837 | 51 |
News Archive
Nina Balthasar and her colleagues have presented direct evidence that the fat hormone leptin affects a specific type of target neurons in the brain - a prime link in the brain's regulation of the body's energy balance.
Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria.
New research from Queen Mary, University of London suggests that many cases of diabetes could be prevented by making use of existing prediction tools.
DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.
› Verified 5 days ago
| Entity Name | Privia Medical Group Washington Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780658419 PECOS PAC ID: 2264320837 Enrollment ID: O20040309000126 |
News Archive
Nina Balthasar and her colleagues have presented direct evidence that the fat hormone leptin affects a specific type of target neurons in the brain - a prime link in the brain's regulation of the body's energy balance.
Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria.
New research from Queen Mary, University of London suggests that many cases of diabetes could be prevented by making use of existing prediction tools.
DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Grace Castillo, ARNP 55 W Tietan St, Walla Walla, WA 99362-4445 Ph: (509) 525-3720 | Emily Grace Castillo, ARNP 55 W Tietan St, Walla Walla, WA 99362-4445 Ph: (509) 525-3720 |
News Archive
Nina Balthasar and her colleagues have presented direct evidence that the fat hormone leptin affects a specific type of target neurons in the brain - a prime link in the brain's regulation of the body's energy balance.
Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria.
New research from Queen Mary, University of London suggests that many cases of diabetes could be prevented by making use of existing prediction tools.
DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.
› Verified 5 days ago
Patrick R Smart, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 401 W Poplar St, Sleep Medicine Center, Walla Walla, WA 99362 Phone: 509-522-5946 Fax: 509-522-5527 | |
Delila C Ojeda, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1111 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-522-0100 Fax: 509-527-8010 | |
Hyunjin Eo, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1017 S 2nd Ave Ste 1, Walla Walla, WA 99362 Phone: 509-398-9699 | |
Ms. Leikin Louise Patrick, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 380 Chase Ave, Walla Walla, WA 99362 Phone: 509-897-3333 | |
Mary Buriani, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1111 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-527-8151 Fax: 509-527-8010 | |
Susan D Collins, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1111 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-522-0100 Fax: 509-527-8010 |